EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxidative Stress in Osteoclast Metabolism in Chronic Kidney Disease: Drivers and Implications for Bone Disease Treatment—A Narrative Review

Kuo-Cheng Lu, Tu-Chen Chung, Wen-Fang Chiang, Jenq-Shyong Chan, Li-Yen Huang, Chung-Chi Yang, Po-Jen Hsiao

Antioxidants · 20.11.2026 · 15 (11) · 1518

DOI: 10.3390/antiox15111518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 20.11.2026. Verfasst von Kuo-Cheng Lu und 6 weiteren Autor:innen. Die Arbeit nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taoyuan Armed Forces General Hospital, Ministry of National Defense, Medical Affairs Bureau, Teh-Tzer Study Group for Human Medical Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease–mineral and bone disorder (CKD-MBD) comprises several bone-turnover phenotypes and carries a high risk of fracture. In this narrative review, we examine how reactive oxygen species (ROS) regulate osteoclast differentiation driven by receptor activator of nuclear factor-κB ligand (RANKL), and how uremic solutes, secondary hyperparathyroidism, disturbances of phosphate, fibroblast growth factor 23 (FGF23), and Klotho, inflammation, and weakened antioxidant defenses may alter this response in CKD. We also outline the metabolic programme of the osteoclast lineage, including mitochondrial biogenesis, glycolytic adaptation, NADPH and glutamine supply and hypoxia signalling, and relate it to ROS generation and antioxidant defence. Because bone is remodelled by osteoclasts, osteoblasts and osteocytes together, we summarise redox effects in these cells and consider how oxidative stress may contribute to low-turnover as well as high-turnover disease. Gut dysbiosis may contribute through microbial toxin precursors, intestinal barrier dysfunction, and reduced production of short-chain fatty acids, although the evidence for these gut–bone links is mainly mechanistic and hypothesis-generating. Experimental work implicates NF-κB, MAPK, AKT/FOXO, and Keap1/Nrf2 signaling, although the direction and clinical weight of gut-derived and redox effects probably differ between high- and low-turnover disease. Direct evidence from human CKD bone is scarce, and no antioxidant or microbiota-targeted intervention has yet been shown to prevent fractures. Oxidative-stress biomarkers are not standardised in CKD and have not been validated, alone or with bone-turnover markers, for selecting patients for redox-targeted treatment. For now, management should rest on fracture risk, serial CKD-MBD biochemistry, assessment of bone turnover where indicated, and the safety of antiresorptive drugs in advanced CKD. Prospective studies that measure microbial metabolites, redox markers, bone turnover and structure, and fractures together are needed to establish whether these pathways are worth targeting.

Förderung

  • Taoyuan Armed Forces General Hospital
  • Ministry of National Defense, Medical Affairs Bureau
  • Teh-Tzer Study Group for Human Medical Research Foundation

Zitieren

APA

Lu, K., Chung, T., Chiang, W., Chan, J., Huang, L., Yang, C., & Hsiao, P. (2026). Oxidative Stress in Osteoclast Metabolism in Chronic Kidney Disease: Drivers and Implications for Bone Disease Treatment—A Narrative Review. Antioxidants, 15(11), 1518. https://doi.org/10.3390/antiox15111518

Vancouver

Lu K, Chung T, Chiang W, Chan J, Huang L, Yang C, et al. Oxidative Stress in Osteoclast Metabolism in Chronic Kidney Disease: Drivers and Implications for Bone Disease Treatment—A Narrative Review. Antioxidants. 2026;15(11):1518. doi:10.3390/antiox15111518

BibTeX
@article{Lu2026,
  author = {Lu, Kuo-Cheng and Chung, Tu-Chen and Chiang, Wen-Fang and Chan, Jenq-Shyong and Huang, Li-Yen and Yang, Chung-Chi and Hsiao, Po-Jen},
  title = {Oxidative Stress in Osteoclast Metabolism in Chronic Kidney Disease: Drivers and Implications for Bone Disease Treatment—A Narrative Review},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1518},
  doi = {10.3390/antiox15111518}
}
Kostenlos starten →